New York, New York--(Newsfile Corp. - November 17, 2020) - Enthusiasm is surrounding Pfizer's and Moderna's announcement of COVID-19 vaccine candidates that may soon become ripe for approval. But, in all fairness to the progress, tempering some of the excitement is warranted. There are two significant concerns. First, both Pfizer… Read More..

By David Bautz, PhD NASDAQ:SNGX READ THE FULL CERC RESEARCH REPORT Business Update Topline Results for SGX942 in 4Q20 Soligenix, Inc. (NASDAQ:SNGX) is currently conducting the Phase 3 DOM-INNATE (Dusquetide treatment in Oral Mucositis – by modulating INNATE immunity) trial of SGX942 in the treatment of oral mucositis (OM) in… Read More..

GIG HARBOR, Wash., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Harbor Custom Development, Inc. (“Harbor,” “Harbor Custom Homes®,” or the “Company”), (NASDAQ:HCDI), an innovative and market leading real estate company involved in all aspects of the land development cycle, today announced consolidated financial results for the third quarter ended September 30,… Read More..